Page last updated: 2024-10-26

dipyridamole and Anemia, Hemolytic, Autoimmune

dipyridamole has been researched along with Anemia, Hemolytic, Autoimmune in 2 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Anemia, Hemolytic, Autoimmune: Acquired hemolytic anemia due to the presence of AUTOANTIBODIES which agglutinate or lyse the patient's own RED BLOOD CELLS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Poldre, P1
Pruzanski, W1
Chiu, HM1
Dotten, DA1
Matloff, JM1

Reviews

1 review available for dipyridamole and Anemia, Hemolytic, Autoimmune

ArticleYear
Surgery for aortic valve disease.
    Cardiovascular clinics, 1971, Volume: 3, Issue:2

    Topics: Anemia, Hemolytic; Anemia, Hemolytic, Autoimmune; Animals; Anticoagulants; Aortic Valve Insufficienc

1971

Other Studies

1 other study available for dipyridamole and Anemia, Hemolytic, Autoimmune

ArticleYear
Fulminant gangrene in transient cold agglutinemia associated with Escherichia coli infection.
    Canadian Medical Association journal, 1985, Feb-01, Volume: 132, Issue:3

    Topics: Anemia, Hemolytic, Autoimmune; Cryoglobulins; Cytotoxicity, Immunologic; Dipyridamole; Endocarditis,

1985